Advertisement

Reactions Weekly

, Volume 1777, Issue 1, pp 170–170 | Cite as

Multiple drugs

Development of resistance: 14 case reports
Case report
  • 65 Downloads

Reference

  1. Yoda S, et al. Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer. Cancer Discovery 8: 714-729, No. 6, Jun 2018. Available from: URL: http://doi.org/10.1158/2159-8290.CD-17-1256 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations